Cystic fibrosis learning network telehealth innovation lab during the COVID-19 pandemic: a success QI story for interdisciplinary care and agenda setting

Dana Albon,Lacrecia Thomas,Lindsay Hoberg,Sophia Stamper,Lindsay Somerville,Prigi Varghese,Ella Balasa,Matthew Roman,Maria T Britto,Melanie Miner,Emily Gehring,Clifford Gammon,Raouf S Amin,Michael Seid,Mike Powers,CF Learning Network telehealth iLab working group,Cori Daines,Glenda Drake,Amy Lucero,Lilly Mees,Amanda Sharpe,Gregory Sawicki,Rachel Gordon,Lucinda Murphy,Ahmet Uluer,Lindsey McMahon,Melanie Abdelnour,Meghan Murray,Meghana Sathe,Preeti Sharma,Traci Liberto,Rachel Linnemann,Sydney Schiff,Alexia Hernandez Cargal,Heather Tucker,Pornchai Tirakitsoontorn,Maivy Sou,Alicia Maciel,Michael Schechter,Andrea Molzhon,Nicholas Antos,Nicole Brueck,Karen Wunschel,Christopher M Siracusa,Lisa A Mullen,Kyle Traver,Travis Burgett,Alex Gifford,Nicola Felicetti,Heidi Dolan,Tracey Gendreau,Danielle Beachler,Shine-Ann Pai,Stephanie Robbins,Zoe Orcutt,Ben McCullar,Lindsaey Deveaux,Christian Merlo,Lauren Mitchell,Andrew Scaljon,Rebekah Brown,Stefanie Rushing,Virginia Birnbaum,Hossein Sadeghi,Golnar Raissi,Bean Corcoran,Michelle Prickett,Rachel Nelson,Joanne Cullina,Fadi Asfour,Anne Snuggerud,Stacy Allen,Thida Ong,Sabrina Gorry,Lisa Greene,Peter Michelson,Sara Renschen,Mike Price,Betsy Price,Catherine Kier,Teresa Carney,Sandy Corr,Barbara Leyva,Jillian Salvatore,George M Solomon,Julianna Bailey,James Lawlor,Samya Z Nasr,Rebekah Raines,Catherine Enochs,Jordan Dunitz,Kristen Jesse,Kayla Warner,Jonathan Flath,Mackenzie Wharram,Deborah Froh,Holly Carroll-Owens,Rhonda List,Lauren Williamson,James Tolle,Susan Eastman,Marrisa Benchea,Nauman Chaudary,Mahsa Farsad,Kimberly Wingo,Kathryn Moffett,Erin Brozik,Jillian Huffman
DOI: https://doi.org/10.1136/bmjoq-2022-001844
Abstract:Introduction: The Cystic Fibrosis Foundation chronic care guidelines recommend monitoring clinical status of a patient with cystic fibrosis (CF) through quarterly interdisciplinary visits. At the beginning of the COVID-19 pandemic, the Cystic Fibrosis Learning Network (CFLN) designed and initiated a telehealth (TH) innovation lab (TH ILab) to support transition from the classic CF care model of quarterly in-person office visits to a care model that included TH. Aim: The specific aims of the TH ILab were to increase the percentage of virtual visits with interdisciplinary care (IDC) from 60% to 85% and increase the percentage of virtual visits in which patients and families participated in shared agenda setting (AS) from 52% to 85% by 31 December 2020. Methods: The model for improvement methodology was used to determine the ILab aims, theory, interventions and measures. In the testing phase of the ILab, data related to process and outcome measures as well as learnings from plan-do-study-act cycles were collected, analysed and shared weekly with the TH ILab teams. Participating centres created processes for IDC and AS for TH visits and developed and shared quality improvement tools specific to their local context with other centres during the ILab weekly meetings and via a secure CFLN-maintained platform. Results: Both specific aims were achieved ahead of the expected target date. By August 2020, 85% of the TH ILab visits provided IDC and 92% of patients were seen for CF care by teams from the TH ILab that participated in AS. Conclusion: Shared learning through a collaborative, data-driven process in the CFLN TH ILab rapidly led to standardised TH IDC and AS, which achieved reliable and sustainable processes which could be reproduced by other networks.
What problem does this paper attempt to address?